Amrize Ltd (NYSE:AMRZ) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Shares of Amrize Ltd (NYSE:AMRZGet Free Report) have earned a consensus rating of “Moderate Buy” from the fourteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $58.3333.

Several analysts have commented on the company. JPMorgan Chase & Co. upped their price objective on Amrize from $52.00 to $60.00 and gave the company an “overweight” rating in a research note on Tuesday, August 26th. Weiss Ratings restated a “hold (c)” rating on shares of Amrize in a research note on Thursday, October 30th. Wall Street Zen upgraded shares of Amrize to a “hold” rating in a research report on Saturday, October 25th. Stephens initiated coverage on shares of Amrize in a research note on Friday, November 14th. They issued an “overweight” rating and a $60.00 price objective on the stock. Finally, Morgan Stanley set a $61.00 target price on shares of Amrize and gave the stock an “overweight” rating in a research note on Wednesday, October 29th.

Get Our Latest Report on AMRZ

Amrize Stock Performance

NYSE AMRZ opened at $51.51 on Wednesday. The company has a current ratio of 1.38, a quick ratio of 0.85 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $28.49 billion and a price-to-earnings ratio of 27.99. Amrize has a one year low of $44.12 and a one year high of $56.29. The company has a fifty day simple moving average of $49.16.

Amrize (NYSE:AMRZGet Free Report) last announced its earnings results on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.03). The firm had revenue of $3.68 billion for the quarter, compared to analyst estimates of $3.49 billion. Amrize’s quarterly revenue was up 6.6% on a year-over-year basis.

Insider Activity

In other Amrize news, insider Jaime Hill acquired 4,000 shares of the stock in a transaction on Tuesday, November 4th. The shares were bought at an average price of $50.69 per share, with a total value of $202,760.00. Following the acquisition, the insider owned 18,101 shares of the company’s stock, valued at $917,539.69. This trade represents a 28.37% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nicholas C. Gangestad bought 2,000 shares of the company’s stock in a transaction on Wednesday, November 19th. The shares were acquired at an average price of $47.34 per share, for a total transaction of $94,680.00. Following the transaction, the director directly owned 4,958 shares in the company, valued at $234,711.72. This trade represents a 67.61% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have bought 65,000 shares of company stock worth $3,399,720 in the last three months.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of AMRZ. State of Wyoming purchased a new position in shares of Amrize in the third quarter valued at $32,000. US Bancorp DE purchased a new stake in shares of Amrize in the 3rd quarter worth about $38,000. Costello Asset Management INC acquired a new stake in Amrize in the 3rd quarter valued at about $44,000. Global Retirement Partners LLC acquired a new stake in Amrize in the 3rd quarter valued at about $48,000. Finally, Jones Financial Companies Lllp purchased a new position in Amrize during the 3rd quarter valued at about $53,000.

About Amrize

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.